Shares of Solventum jumped Tuesday and led S&P 500 gainers intraday after medical device maker Thermo Fisher Scientific said it would acquire the company’s purification and filtration business for $4.

Thermo Fisher Scientific is acquiring Solventum’s purification & filtration business unit in a cash deal worth around $4.1bn. Solventum’s unit produces purification and filtration solutions ...

Thermo Fisher Scientific TMO has entered into a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biological Imaging (CZ Imaging Institute). The collaboration aims to ...

The deal will add about a billion in sales, suggesting that about a 4 times sales multiple has been paid. In comparison, Thermo Fisher commands a $203 billion equity valuation at $530 per share ...

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 ...

--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE ... s Purification & Filtration business for approximately $4.1 billion in cash. Solventum’s Purification & Filtration business is a ...

Forbes contributors publish independent expert analyses and insights. Thermo Fisher Scientific provides products and services that support the life sciences industry, including large ...

Presently, Thermo Fisher boasts a market capitalization of $208.55 billion. The company’s earnings yield of 4.5% is well ahead of the industry’s -3.5% yield. It surpassed earnings estimates in ...